MEDPACE HOLDINGS INC (MEDP)
US58506Q1094 - Common Stock
ChartMill assigns a Buy % Consensus number of 83% to MEDP. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 431.26. This target is 8.92% above the current price.
MEDP was analyzed by 12 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about MEDP.
In the previous month the buy percentage consensus was at a similar level.
MEDP was analyzed by 12 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2024-04-24 | Guggenheim | Maintains | Buy -> Buy |
| 2024-04-24 | Baird | Maintains | Outperform -> Outperform |
| 2024-04-23 | Jefferies | Upgrade | Hold -> Buy |
| 2024-03-18 | Deutsche Bank | Initiate | Hold |
| 2024-03-08 | UBS | Maintains | Buy -> Buy |
| 2024-02-15 | UBS | Upgrade | Neutral -> Buy |
| 2024-02-14 | Baird | Maintains | Outperform -> Outperform |
| 2024-01-17 | Baird | Maintains | Outperform -> Outperform |
| 2023-10-24 | Baird | Upgrade | Neutral -> Outperform |
| 2023-07-25 | Guggenheim | Maintains | Buy -> Buy |
| 2023-05-08 | Guggenheim | Upgrade | Neutral -> Buy |
| 2023-02-15 | Baird | Maintains | Neutral |
| 2022-10-27 | UBS | Upgrade | Sell -> Neutral |
| 2022-10-26 | Baird | Maintains | Neutral |
| 2022-09-07 | UBS | Initiate | Sell |
| 2022-05-24 | Guggenheim | Initiate | Neutral |
| 2021-07-20 | Credit Suisse | Maintains | Outperform |
| 2021-03-17 | Credit Suisse | Maintains | Outperform |
| 2021-02-17 | Truist Securities | Maintains | Buy |
| 2021-02-16 | Credit Suisse | Maintains | Outperform |